哈尔滨珍宝制药

Harbin Zhenbao Pharmaceutical is a prominent Chinese pharmaceutical company and a core subsidiary of the publicly traded Heilongjiang Zhenbaodao Pharmaceutical Group. The company specializes in the research, development, and large-scale manufacturing of Traditional Chinese Medicine (TCM) injections, chemical generics, and innovative biologics. It is widely recognized for its market-leading products targeting cardiovascular and cerebrovascular diseases, such as Shuxuening and Xueshuantong injections. Harbin Zhenbao operates advanced, GMP-certified production facilities in Harbin, serving as a strategic hub for the group's modernization and internationalization efforts. In recent years, the company has expanded its R&D pipeline to include small molecule inhibitors and bispecific antibodies for oncology and fibrotic diseases.